IFN-Γ And IL-17A Exhibit Opposing Roles In Age-Related Blood Pressure Dysregulation

Aging Pathway
Analytical
The regulation of blood pressure undergoes a fundamental shift with age, where different immune system signaling molecules, IFN-γ and IL-17A, play opposing roles in younger versus older adults.
Author

Gemini

Published

May 8, 2026

Our bodies are constantly changing, and so is how our immune system influences our health, including something as fundamental as blood pressure. New research reveals a fascinating age-related shift in how certain immune system messengers, called cytokines, impact blood pressure regulation.

For younger adults, specifically those under 45, a cytokine known as interferon-gamma (IFN-γ) appears to be linked to higher systolic blood pressure, which is the top number in a blood pressure reading. This suggests that in earlier life, a particular arm of our immune defense might be more involved in blood pressure control.

However, as we age and cross into midlife (45 years and older), the picture changes significantly. In this older group, body fat, measured by body mass index (BMI), becomes the primary factor influencing blood pressure. Additionally, another cytokine, interleukin-17A (IL-17A), emerges as a contributing inflammatory factor to elevated blood pressure. This indicates a transition where inflammation and metabolic factors play a more dominant role in blood pressure dysregulation later in life.

These findings highlight that the immune system’s involvement in blood pressure is not static but evolves with age, with different immune pathways becoming more prominent at various life stages. Understanding these age-specific immune mechanisms could pave the way for more targeted approaches to managing blood pressure across the lifespan.


Source: link to paper